OXAGEN LLC

Organization

AVENTURA, FL, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Treatment of CRTH2-mediated diseases and conditions
- Patent number 8,314,257
- Issue date Nov 20, 2012
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds having CRTH2 antagonist activity
- Patent number 8,268,878
- Issue date Sep 18, 2012
- Oxagen Limited
- Richard Edward Armer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of CRTH2-mediated diseases and conditions
- Patent number 8,198,314
- Issue date Jun 12, 2012
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds having CRTH2 antagonist activity
- Patent number 8,168,673
- Issue date May 1, 2012
- Oxagen Limited
- Richard Edward Armer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of CRTH2-mediated diseases and conditions
- Patent number 8,163,936
- Issue date Apr 24, 2012
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of CRTH2-mediated diseases and conditions
- Patent number 8,163,931
- Issue date Apr 24, 2012
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
1-acetic acid-indole derivatives with PGD2 antagonist activity
- Patent number 8,044,088
- Issue date Oct 25, 2011
- Oxagen Limited
- Richard Edward Armer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds having CRTH2 antagonist activity
- Patent number 7,999,119
- Issue date Aug 16, 2011
- Oxagen Limited
- Richard Edward Armer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds having CRTH2 antagonist activity
- Patent number 7,919,512
- Issue date Apr 5, 2011
- Oxagen Limited
- Richard Edward Armer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds having CRTH2 antagonist activity
- Patent number 7,750,027
- Issue date Jul 6, 2010
- Oxagen Limited
- Richard Edward Armer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for the treatment of CRTH2-mediated diseases and conditions
- Patent number 7,582,672
- Issue date Sep 1, 2009
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for detection of MIP-4 and CCRL2 binding and activity modula...
- Patent number 7,521,194
- Issue date Apr 21, 2009
- Oxagen Limited
- Jonathon Mark Tinsley
- G01 - MEASURING TESTING

Patents Applicationslast 30 patents

Information Patent Application
CRTH2 Antagonists for Treatment of Eosinophilic Diseases and Condit...
- Publication number 20130052190
- Publication date Feb 28, 2013
- Oxagen Limited
- Lisa Pearce Collins
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds Having CRTH2 Antagonist Activity
- Publication number 20110268693
- Publication date Nov 3, 2011
- Oxagen Limited
- Richard Edward ARMER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds Having CRTH2 Antagonist Activity
- Publication number 20110142855
- Publication date Jun 16, 2011
- Oxagen Limited
- Richard Edward ARMER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds Having CRTH2 Antagonist Activity
- Publication number 20110123547
- Publication date May 26, 2011
- Oxagen Limited
- Richard Edward ARMER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of CRTH2 Antagonist Compounds
- Publication number 20110124683
- Publication date May 26, 2011
- Oxagen Limited
- Michael George Hunter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
1-ACETIC ACID-INDOLE DERIVATIVES WITH PGD2 ANTAGONIST ACTIVITY
- Publication number 20100330077
- Publication date Dec 30, 2010
- OXAGEN LIMITED
- Richard Edward Armer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds Having CRTH2 Antagonist Activity
- Publication number 20100266535
- Publication date Oct 21, 2010
- Oxagen Limited
- Richard Edward ARMER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds Having CRTH2 Antagonist Activity
- Publication number 20100063103
- Publication date Mar 11, 2010
- Oxagen Limited
- Richard Edward ARMER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Salts with CRTH2 Antagonist Activity
- Publication number 20100056544
- Publication date Mar 4, 2010
- Oxagen Limited
- James Matthew Lovell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MICROCRYSTALLINE (5-FLUORO-2-METHYL-3-QUINOLIN-2-YLMETHYL-INDOL-1-Y...
- Publication number 20100041699
- Publication date Feb 18, 2010
- OXAGEN LIMITED
- Edward Andrew Boyd
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds Having CRTH2 Antagonist Activity
- Publication number 20100035956
- Publication date Feb 11, 2010
- Oxagen Limited
- Richard Edward Armer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds Having CRTH2 Antagonist Activity
- Publication number 20100022613
- Publication date Jan 28, 2010
- Oxagen Limited
- Richard Edward Armer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds Having CRTH2 Antagonist Activity
- Publication number 20090192195
- Publication date Jul 30, 2009
- Oxagen Limited
- Richard Edward Armer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Treatment of CRTH2-mediated diseases and conditions
- Publication number 20090023788
- Publication date Jan 22, 2009
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of CRTH2-mediated diseases and conditions
- Publication number 20090018138
- Publication date Jan 15, 2009
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of CRTH2-mediated diseases and conditions
- Publication number 20090018139
- Publication date Jan 15, 2009
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of CRTH2-Mediated diseases and conditions
- Publication number 20090018338
- Publication date Jan 15, 2009
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds Having Crth2 Antagonist Activity
- Publication number 20070232681
- Publication date Oct 4, 2007
- Oxagen Limited
- David Middlemiss
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Treatment of CRTH2-mediated diseases and conditions
- Publication number 20050119268
- Publication date Jun 2, 2005
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks

Information Trademark
99172994 - OXAGEN OXA-FLEX
- Serial number 99172994
- Filing date May 7, 2025
- Oxagen LLC
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97615170 - OXAGEN
- Serial number 97615170
- Filing date Sep 30, 2022
- OXAGEN LLC
- 3 - Bleaching preparations and other substances for laundry use
Information Trademark
78226369 - BONECHIP
- Serial number 78226369
- Filing date Mar 17, 2003
- Oxagen Limited
- 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry

Organization

Patents Grantslast 30 patents

Treatment of CRTH2-mediated diseases and conditions

Compounds having CRTH2 antagonist activity

Treatment of CRTH2-mediated diseases and conditions

Compounds having CRTH2 antagonist activity

Treatment of CRTH2-mediated diseases and conditions

Treatment of CRTH2-mediated diseases and conditions

1-acetic acid-indole derivatives with PGD2 antagonist activity

Compounds having CRTH2 antagonist activity

Compounds having CRTH2 antagonist activity

Compounds having CRTH2 antagonist activity

Compounds for the treatment of CRTH2-mediated diseases and conditions

Method for detection of MIP-4 and CCRL2 binding and activity modula...

Patents Applicationslast 30 patents

CRTH2 Antagonists for Treatment of Eosinophilic Diseases and Condit...

Compounds Having CRTH2 Antagonist Activity

Compounds Having CRTH2 Antagonist Activity

Compounds Having CRTH2 Antagonist Activity

Use of CRTH2 Antagonist Compounds

1-ACETIC ACID-INDOLE DERIVATIVES WITH PGD2 ANTAGONIST ACTIVITY

Compounds Having CRTH2 Antagonist Activity

Compounds Having CRTH2 Antagonist Activity

Salts with CRTH2 Antagonist Activity

MICROCRYSTALLINE (5-FLUORO-2-METHYL-3-QUINOLIN-2-YLMETHYL-INDOL-1-Y...

Compounds Having CRTH2 Antagonist Activity

Compounds Having CRTH2 Antagonist Activity

Compounds Having CRTH2 Antagonist Activity

Treatment of CRTH2-mediated diseases and conditions

Treatment of CRTH2-mediated diseases and conditions

Treatment of CRTH2-mediated diseases and conditions

Treatment of CRTH2-Mediated diseases and conditions

Compounds Having Crth2 Antagonist Activity

Treatment of CRTH2-mediated diseases and conditions

Trademarklast 30 trademarks

99172994 - OXAGEN OXA-FLEX

97615170 - OXAGEN

78226369 - BONECHIP